(HLNE) Hamilton Lane - Ratings and Ratios
Private Equity, Venture Capital, Fund Of Funds, Direct Credit, Real Assets
Dividends
| Dividend Yield | 2.02% |
| Yield on Cost 5y | 3.87% |
| Yield CAGR 5y | 12.07% |
| Payout Consistency | 100.0% |
| Payout Ratio | 39.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.0% |
| Value at Risk 5%th | 48.6% |
| Relative Tail Risk | -1.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.66 |
| Alpha | -47.91 |
| CAGR/Max DD | 0.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.511 |
| Beta | 1.442 |
| Beta Downside | 1.347 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.68% |
| Mean DD | 12.02% |
| Median DD | 7.41% |
Description: HLNE Hamilton Lane November 04, 2025
Hamilton Lane Incorporated (NASDAQ:HLNE) is a U.S.–based private-equity and venture-capital manager that originated in 1991 in Conshohocken, Pennsylvania and now operates a global network of offices across Europe, North America, Asia-Pacific, and the Middle East.
The firm runs a broad suite of alternative-investment strategies-including direct credit, fund-of-funds, evergreen vehicles, and real-asset platforms-targeting primary and secondary commitments across private-equity buyouts, special situations, growth equity, mezzanine, and venture-capital funds.
Its investment mandate emphasizes disruptive technologies and innovative business models, with a stated preference for sectors such as alternative energy, water purification, health-care technology, internet software, and other tech-enabled services. Deal sizes typically range from $0.25 million to $100 million, and Hamilton Lane often seeks majority-control positions in companies with small- to mid-size enterprise values.
Geographically, the firm pursues opportunities across a wide footprint that includes the United States (notably California, New York, and Sun Belt states), Europe, Asia-Pacific (including China, India, Korea, and Japan), the Middle East, Africa, and Latin America.
Key performance indicators (as of FY 2023) show $84 billion in assets under management (AUM), a 12% year-over-year increase in fee-related earnings, and a net income margin of roughly 18%. The private-equity market’s fundraising pace-estimated at $1.2 trillion in 2023-provides a robust pipeline of capital, while elevated interest rates are pressuring leveraged-buyout multiples and encouraging a shift toward lower-leverage, credit-focused strategies.
For readers looking to deepen their quantitative analysis, ValueRay offers a granular, data-driven dashboard that can help you benchmark Hamilton Lane’s valuation metrics against peers and track the impact of macro-economic shifts on its portfolio performance.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (230.6m TTM) > 0 and > 6% of Revenue (6% = 42.2m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 5.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 33.37% (prev 18.95%; Δ 14.41pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 360.0m > Net Income 230.6m (YES >=105%, WARN >=100%) |
| Net Debt (195.9m) to EBITDA (418.6m) ratio: 0.47 <= 3.0 (WARN <= 3.5) |
| Current Ratio 39.60 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (54.5m) change vs 12m ago 0.58% (target <= -2.0% for YES) |
| Gross Margin 73.20% (prev 71.98%; Δ 1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.32% (prev 46.69%; Δ -5.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 26.60 (EBITDA TTM 418.6m / Interest Expense TTM 15.4m) >= 6 (WARN >= 3) |
Altman Z'' 3.96
| (A) 0.12 = (Total Current Assets 240.8m - Total Current Liabilities 6.08m) / Total Assets 1.98b |
| (B) 0.27 = Retained Earnings (Balance) 535.2m / Total Assets 1.98b |
| (C) 0.24 = EBIT TTM 408.8m / Avg Total Assets 1.70b |
| (D) 0.65 = Book Value of Equity 536.5m / Total Liabilities 822.3m |
| Total Rating: 3.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 88.95
| 1. Piotroski 6.0pt |
| 2. FCF Yield 4.91% |
| 3. FCF Margin 49.55% |
| 4. Debt/Equity 0.53 |
| 5. Debt/Ebitda 0.47 |
| 6. ROIC - WACC (= 24.37)% |
| 7. RoE 31.25% |
| 8. Rev. Trend 78.11% |
| 9. EPS Trend 48.96% |
What is the price of HLNE shares?
Over the past week, the price has changed by +6.24%, over one month by -1.26%, over three months by -12.69% and over the past year by -26.18%.
Is HLNE a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HLNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 163.5 | 27% |
| Analysts Target Price | 163.5 | 27% |
| ValueRay Target Price | 145.1 | 12.7% |
HLNE Fundamental Data Overview December 05, 2025
P/E Trailing = 22.2094
P/E Forward = 20.4499
P/S = 9.4236
P/B = 6.5508
P/EG = 1.39
Beta = 1.347
Revenue TTM = 703.4m USD
EBIT TTM = 408.8m USD
EBITDA TTM = 418.6m USD
Long Term Debt = 285.6m USD (from longTermDebt, last quarter)
Short Term Debt = 21.7m USD (from shortTermDebt, last fiscal year)
Debt = 436.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 195.9m USD (from netDebt column, last quarter)
Enterprise Value = 7.10b USD (6.91b + Debt 436.7m - CCE 240.8m)
Interest Coverage Ratio = 26.60 (Ebit TTM 408.8m / Interest Expense TTM 15.4m)
FCF Yield = 4.91% (FCF TTM 348.5m / Enterprise Value 7.10b)
FCF Margin = 49.55% (FCF TTM 348.5m / Revenue TTM 703.4m)
Net Margin = 32.78% (Net Income TTM 230.6m / Revenue TTM 703.4m)
Gross Margin = 73.20% ((Revenue TTM 703.4m - Cost of Revenue TTM 188.5m) / Revenue TTM)
Gross Margin QoQ = 70.80% (prev 69.59%)
Tobins Q-Ratio = 3.59 (Enterprise Value 7.10b / Total Assets 1.98b)
Interest Expense / Debt = 0.88% (Interest Expense 3.83m / Debt 436.7m)
Taxrate = 11.89% (14.0m / 117.6m)
NOPAT = 360.2m (EBIT 408.8m * (1 - 11.89%))
Current Ratio = 39.60 (Total Current Assets 240.8m / Total Current Liabilities 6.08m)
Debt / Equity = 0.53 (Debt 436.7m / totalStockholderEquity, last quarter 825.8m)
Debt / EBITDA = 0.47 (Net Debt 195.9m / EBITDA 418.6m)
Debt / FCF = 0.56 (Net Debt 195.9m / FCF TTM 348.5m)
Total Stockholder Equity = 737.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.64% (Net Income 230.6m / Total Assets 1.98b)
RoE = 31.25% (Net Income TTM 230.6m / Total Stockholder Equity 737.8m)
RoCE = 39.94% (EBIT 408.8m / Capital Employed (Equity 737.8m + L.T.Debt 285.6m))
RoIC = 35.07% (NOPAT 360.2m / Invested Capital 1.03b)
WACC = 10.70% (E(6.91b)/V(7.34b) * Re(11.33%) + D(436.7m)/V(7.34b) * Rd(0.88%) * (1-Tc(0.12)))
Discount Rate = 11.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.47%
[DCF Debug] Terminal Value 69.47% ; FCFE base≈278.9m ; Y1≈314.9m ; Y5≈425.8m
Fair Price DCF = 100.8 (DCF Value 4.43b / Shares Outstanding 44.0m; 5y FCF grow 14.98% → 3.0% )
EPS Correlation: 48.96 | EPS CAGR: 5.27% | SUE: 1.78 | # QB: 2
Revenue Correlation: 78.11 | Revenue CAGR: 21.59% | SUE: 0.91 | # QB: 1
EPS current Year (2026-03-31): EPS=5.70 | Chg30d=+0.647 | Revisions Net=+4 | Growth EPS=+13.1% | Growth Revenue=+8.5%
EPS next Year (2027-03-31): EPS=6.17 | Chg30d=+0.147 | Revisions Net=+3 | Growth EPS=+8.1% | Growth Revenue=+15.9%
Additional Sources for HLNE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle